Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre's 10-year experience.

@article{Windsor2001PredictorsOR,
  title={Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre's 10-year experience.},
  author={Phyllis M Windsor},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2001},
  volume={13 3},
  pages={219-27}
}
  • Phyllis M Windsor
  • Published 2001 in
    Clinical oncology (Royal College of Radiologists…
An analysis of prospectively collected data from 75 patients with bone metastases secondary to prostate cancer who were treated with strontium-89 injection in a single centre over a 10-year period, is presented. The surrogate role of markers of disease progression (haemoglobin and prostate specific (PSA) antigen levels; number of bone scan-positive sites… CONTINUE READING